https://www.selleckchem.com/pr....oducts/oxidopamine-h
To compare the adipose and muscle tissue areas in patients who responded differently to neoadjuvant chemotherapy. One hundred and eighty six patients diagnosed with breast cancer who underwent neoadjuvant chemotherapy between January 2015- October 2019 and were operated after the treatment were retrospectively included in the study. Pathological results were divided into five groups using the Miller-Payne grading systems. Grade 1 indicating no significant reduction in malignant cells; Grade 2 a minor loss of malignant c